NR0B1
MOLECULAR TARGETnuclear receptor subfamily 0 group B member 1
NR0B1 (nuclear receptor subfamily 0 group B member 1) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NR0B1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Vorinostat | 1.61 | 4 |
| 2 | Demecolcine | 1.39 | 3 |
| 3 | kenpaullone | 1.39 | 3 |
| 4 | Nocodazole Nocodazole is | 1.39 | 3 |
| 5 | Podophyllotoxin | 1.39 | 3 |
| 6 | chrysin | 1.10 | 2 |
| 7 | Resveratrol | 1.10 | 2 |
| 8 | Bromodeoxyuridine | 1.10 | 2 |
| 9 | calycosin | 1.10 | 2 |
| 10 | Colchicine | 1.10 | 2 |
| 11 | vinblastine sulfate | 1.10 | 2 |
| 12 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 13 | Thioctic Acid | 0.69 | 1 |
| 14 | Genistein | 0.69 | 1 |
| 15 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 16 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 17 | Dasatinib | 0.69 | 1 |
| 18 | fluoranthene | 0.69 | 1 |
| 19 | Folic Acid | 0.69 | 1 |
| 20 | Leflunomide | 0.69 | 1 |
| 21 | Lovastatin | 0.69 | 1 |
| 22 | Niclosamide | 0.69 | 1 |
| 23 | tyrphostin ag 1295 | 0.69 | 1 |
| 24 | Vincamine | 0.69 | 1 |
About NR0B1 as a Drug Target
NR0B1 (nuclear receptor subfamily 0 group B member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented NR0B1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NR0B1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.